ADTXAditxt, Inc.

Nasdaq aditxt.com


$ 0.49 $ -0.01 (-1.61 %)    

Wednesday, 11-Sep-2024 14:56:21 EDT
QQQ $ 468.28 $ 9.96 (2.17 %)
DIA $ 409.73 $ 1.01 (0.25 %)
SPY $ 554.79 $ 5.63 (1.03 %)
TLT $ 100.61 $ -0.08 (-0.08 %)
GLD $ 232.25 $ -0.37 (-0.16 %)
$ 0.488
$ 0.46 x 200
-- x --
-- - --
$ 0.42 - $ 27.82
131,073
na
1.76M
$ 3.09
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-19-2024 06-30-2024 10-Q
2 05-20-2024 03-31-2024 10-Q
3 04-16-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 04-17-2023 12-31-2022 10-K
8 11-14-2022 09-30-2022 10-Q
9 08-15-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-31-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-12-2021 06-30-2021 10-Q
14 05-12-2021 03-31-2021 10-Q
15 03-25-2021 12-31-2020 10-K
16 11-13-2020 09-30-2020 10-Q
17 08-13-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Aditxt, Inc. ("Aditxt" or "the Company") (NASDAQ:ADTX), an innovation platform dedicated to discovering, develo...

Core News & Articles

As the popularity of GLP-1 receptor agonists continues to surge in the treatment of obesity and type 2 diabetes, Evofem Bioscie...

Core News & Articles

Appili, with a commercial-stage pipeline, has raised CAD $100M towards developing therapeutics for the global infectious diseas...

 whats-going-on-with-aditxt-shares-wednesday

Aditxt and Evofem amended and restated their merger agreement.

Core News & Articles

This amended and restated Merger Agreement, among others, addresses pre-closing issues critical for Evofem's future success...

 evofem-biosciences-announces-issuance-of-us-patent-no-11992472-covering-composition-and-methods-for-contraception-with-phexxi-vaginal-gel

- Issuance of U.S. Patent No. 11,992,472 Further Strengthens Evofem's Intellectual Patent Portfolio --- Newly issued patent...

 aditxt-announces-pricing-of-42m-private-placement-priced-at-the-market-under-nasdaq-rules

Aditxt, Inc. (NASDAQ:ADTX) ("Aditxt" or the "Company"), a company dedicated to discovering, developing, and dep...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION